Medicare Enrolled
Dr. James Belarmino, MD
Urology Physician · Latham, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Belarmino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Belarmino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Belarmino
Dr. James Belarmino is an urology physician in Latham, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Belarmino performed 877 Medicare services across 719 unique beneficiaries.
Between the years covered by Open Payments, Dr. Belarmino received a total of $13,725 from 53 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Belarmino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ 877 Medicare services
$13,725 industry payments
Medicare Practice Summary
Medicare Utilization ↗877
Medicare services
Bottom 44% in NY for urology physician
719
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $89 | $210 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
113 | $174 | $754 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $58 | $141 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
102 | $7 | $50 |
| PSA test (prostate cancer screening) | 75 | $18 | $51 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $111 | $324 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
55 | $38 | $101 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
39 | $8 | $20 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
31 | $184 | $800 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
31 | $45 | $338 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $128 | $283 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $19 | $36 |
| Cystourethrogram An X-ray imaging procedure performed by injecting contrast material through the bladder and urethra to visualize the urinary tract. |
15 | $24 | $135 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $157 | $411 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $90 | $205 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $228 | $750 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
13 | $3 | $12 |
| New patient office visit, complex (60-74 min) | 12 | $140 | $405 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
20.5% medium
78.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,725
Total received (2018-2024)
Avg $1,961/year across 7 years
Top 15% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,116 (88.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,609 (11.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,431
2023
$2,471
2022
$1,788
2021
$2,109
2020
$593
2019
$3,287
2018
$1,046
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$707
Axonics, Inc.
$352
Astellas Pharma US Inc
$333
Merck Sharp & Dohme LLC
$202
Sumitomo Pharma America, Inc.
$189
PFIZER INC.
$109
Myriad Genetic Laboratories, Inc.
$109
Tolmar, Inc.
$93
ABBVIE INC.
$61
Boston Scientific Corporation
$58
Medtronic, Inc.
$55
Olympus America Inc.
$34
Novartis Pharmaceuticals Corporation
$26
UROGEN PHARMA, INC.
$24
Janssen Biotech, Inc.
$22
ACCORD HEALTHCARE, INC.
$21
Laborie Medical Technologies Corp.
$20
COLOPLAST CORP
$17
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$3,537
Intuitive Surgical, Inc.
$2,520
Astellas Pharma US Inc
$1,873
Boston Scientific Corporation
$743
Axonics, Inc.
$450
PFIZER INC.
$386
Sumitomo Pharma America, Inc.
$350
Merck Sharp & Dohme LLC
$333
UROVANT SCIENCES INC
$331
NeoTract Inc.
$261
Olympus America Inc.
$251
ABBVIE INC.
$237
AbbVie Inc.
$207
Endo Pharmaceuticals Inc.
$161
Coloplast Corp
$142
Janssen Biotech, Inc.
$137
Allergan, Inc.
$132
Avadel Specialty Pharmaceuticals, LLC
$132
Tolmar, Inc.
$131
Axonics Modulation Technologies, Inc.
$125
Myriad Genetic Laboratories, Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$107
Janssen Products, LP
$99
Merck Sharp & Dohme Corporation
$97
Hollister Incorporated
$75
Alnylam Pharmaceuticals Inc.
$69
Medtronic, Inc.
$55
AbbVie, Inc.
$55
Accord Healthcare, Inc.
$53
Allergan Inc.
$52
180 Medical, Inc.
$38
COLOPLAST CORP
$37
Amgen Inc.
$37
Antares Pharma, Inc.
$32
C. R. Bard, Inc. & Subsidiaries
$31
Pharmacyclics LLC, an AbbVie Company
$26
Novartis Pharmaceuticals Corporation
$26
TherapeuticsMD, Inc.
$25
UROGEN PHARMA, INC.
$24
Vanda Pharmaceuticals Inc.
$24
ACCORD HEALTHCARE, INC.
$21
Novo Nordisk Inc
$21
Laborie Medical Technologies Corp.
$20
Myovant Sciences Inc.
$20
Medtronic USA, Inc.
$19
Ethicon US, LLC
$17
ROCHESTER MEDICAL CORPORATION
$16
Siemens Medical Solutions USA, Inc.
$15
Covidien LP
$15
Rochester Medical Corporation
$13
C. R. BARD, INC. & SUBSIDIARIES
$13
C. R. BARD FOUNDATION, INC.
$13
GlaxoSmithKline, LLC.
$12
Top 3 companies account for 57.8% of all-time payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AMS 700 · ANNOVERA · ANORO ELLIPTA · AVEED · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CONTINENCE CARE · CURE CATHETER · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GIVLAARI · GREENLIGHT · Hetlioz · IMBRUVICA · IMVEXXY · INTERSTIM · JELMYTO · Juniper · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · Noctiva · ONLI · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otezla · PLUVICTO · PREMARIN · PROLARIS · Rezum Generator · Rybelsus · SPEEDICATH · Signia · SpeediCath · URETERO-RENO FIBERSCOPE · UROLIFT · UroLift · UroLift System · UroPass · VAPRO · VESICARE · VISTASEAL · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
52
Per 100K population
16.5
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Belarmino is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Belarmino experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Belarmino performed 126 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Belarmino receive payments from pharmaceutical companies?
Yes. Dr. Belarmino received a total of $13,725 from 53 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Belarmino's costs compare to other urology physicians in Latham?
Dr. Belarmino's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Belarmino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Latham
Browse urology physicians in Latham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology